Search Results 661-670 of 16994 for monoclonal antibody
Monoclonal antibodies, such as cetuximab, can interfere with tumor growth by blocking the ability of tumor cells to grow and spread. Tivantinib may stop the ...
The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We ...
-History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...
The purpose of this study is to learn more about Lewy Body disease and a skin condition called Bullous Pemphigoid. Participation eligibility. Participant ...
A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...
If you are eligible for a prescription treatment, such as monoclonal antibody therapy or antiviral medication, your health care provider would be able to ...
Monoclonal antibodies;; Anti-HER2 or other "targeted" (e.g., mTOR) therapy. *Note: Any adverse events derived from these therapies must be ≤ Grade 2 prior ...
The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e. ...
About this study. The purpose of this research is to validate new testing methods for diagnosing patients with Treponema pallidum (syphilis).
Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.